ESR1 and neoplasm: Clinical parameters such as tumor size, lymph node involvement, histological grade, age and the expression of estrogen receptor (ER), progesterone receptor (PGR), and epidermal growth factor receptor 2 (HER2) biomarkers are responsible of its high clinical heterogeneity [84].